Showing results (421-430 of 512) with videos related to
Sort By:
Pageof 52
Orthopedics|December 8, 2022
An Analysis of Formal Patient Complaints, Risk, and Malpractice Events Involving Orthopedic Trauma Surgeons During a 10-Year PeriodLouis C Grandizio, Daniela F Barreto Rocha, Daniel Hayes, et al.Autoimmunity|October 9, 2012
Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) miceCaylib A Durand, Martin J Richer, Kathrin Brenker, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Terminal deoxynucleotidyltransferase deficiency decreases autoimmune disease in diabetes-prone nonobese diabetic mice and lupus-prone MRL-Fas(lpr) miceIan F Robey, Melissa Peterson, Marc S Horwitz, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2004
Optimization of a synthetic beta-catenin-dependent promoter for tumor-specific cancer gene therapyKai S Lipinski, Hakim A Djeha, Jonathan Gawn, et al.Nature Communications|May 4, 2019
Author Correction: Lattice strain-enhanced exsolution of nanoparticles in thin filmsHyeon Han, Jucheol Park, Sang Yeol Nam, et al.Nature Communications|April 2, 2019
Lattice strain-enhanced exsolution of nanoparticles in thin filmsHyeon Han, Jucheol Park, Sang Yeol Nam, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 10, 2017
Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapyD A Barr, A K Coussens, S Irvine, et al.Nanoscale|March 5, 2016
Energy band diagram of device-grade silicon nanocrystalsM Macias-Montero, S Askari, S Mitra, et al.Science Advances|November 25, 2022
Gammaherpesvirus infection drives age-associated B cells toward pathogenicity in EAE and MSIsobel C Mouat, Jessica R Allanach, Naomi M Fettig, et al.Clinical Pharmacology and Therapeutics|May 29, 2009
A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphomaD R Mould, K Sweeney, S B Duffull, et al.Pageof 52